New search | Conferencedetail
mail
Print view
 
 

2nd LNP Characterization and Analytical Development Summit

Evvnt Promotion / evvnt
-
06.11.2024 - 08.11.2024  W Boston, 100 Stuart Street, 02116 Boston, Massachusetts, USA
Time: 8:00 AM - 3:30 PM
 
Conference themes
Turbocharged by increased LNP pipeline development and technological advancements with SPARTA biodiscovery raising $4.3m for their characterization technology, UPENN engineers developing CAR-T therapies, and Genevant securing a $114m deal with Tome. As the industry places a greater emphasis on later-phase assets, understanding the intricacies of LNPs and investing in analytical assays are becoming essential for ensuring market confidence.
Professional congress organizer (PCO)
Hanson Wade
Notes
URL:
Brochure: https://go.evvnt.com/2555692-3?pid=4832

Speakers: Benjamin Hall, Senior Scientist - Analytical Development, Tessera Therapeutics, Carlo Zambonelli PhD, Independent Expert, and more
 

Enquiries and Registration:

https://go.evvnt.com/2555692-2?pid=4832
Ms. Stephanie Nketia
 
Categories
General Medicine
Languages
English
Congress fees
Conference Only - Drug Developer: USD 2999.00, Conference Only - Solution Provider: USD 3699.00, Conference Only - Academics: USD 2599.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

European Public Health Association (EUPHA)Österreichisches Rotes KreuzAnästhesie in Entwicklungsländern e. V.AMREF - African Medical and Research FoundationEuropean Health Forum GasteinCenter of ExcellenceHilfswerk AustriaÄrzte der Welt